Organization and Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2017

Organization and Summary of Significant Accounting Policies

Organization and Summary of Significant Accounting Policies

1.     Organization and business

Incyte Corporation (including its subsidiaries, “Incyte,” “we,” “us,” or “our”) is a biopharmaceutical company focused on developing and commercializing proprietary therapeutics. Our portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products JAKAFI® (ruxolitinib) and ICLUSIG® (ponatinib). Our operations are treated as one operating segment.